In the Clear: Long-term pulmonary function benefits associated with Pseudomonas aeruginosa eradication
Journal of Cystic Fibrosis · 2023
DOI: 10.1016/j.jcf.2023.01.009 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Cystic Fibrosis, 2023. Verfasst von Kimberly M Dickinson und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis, Pseudomonas Infections. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.
- Eudowood Division of Pediatric Respiratory Sciences, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA. Electronic address: mogayze@jhmi.edu.
Zitieren
APA
Dickinson, K. M., & Mogayzel, P. J. (2023). In the Clear: Long-term pulmonary function benefits associated with Pseudomonas aeruginosa eradication. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2023.01.009
Vancouver
Dickinson KM, Mogayzel PJ. In the Clear: Long-term pulmonary function benefits associated with Pseudomonas aeruginosa eradication. Journal of Cystic Fibrosis. 2023. doi:10.1016/j.jcf.2023.01.009
BibTeX
@article{Dickinson2023,
author = {Dickinson, Kimberly M and Mogayzel, Peter J},
title = {In the Clear: Long-term pulmonary function benefits associated with Pseudomonas aeruginosa eradication},
journal = {Journal of Cystic Fibrosis},
year = {2023},
doi = {10.1016/j.jcf.2023.01.009}
}
EUVIMED